Get the latest tech news

There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests

In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.

None

Related news:

Study Claims To Provide First Direct Evidence of Dark Matter

US-China Tension Fuels Decoupling in Tech Research, Study Shows

Ozempic does not slow Alzheimer's, study finds